vs
Side-by-side financial comparison of Apyx Medical Corp (APYX) and Spire Global, Inc. (SPIR). Click either name above to swap in a different company.
Apyx Medical Corp is the larger business by last-quarter revenue ($19.2M vs $15.8M, roughly 1.2× Spire Global, Inc.). Apyx Medical Corp runs the higher net margin — -6.8% vs -176.6%, a 169.9% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs -26.9%). Apyx Medical Corp produced more free cash flow last quarter ($-2.8M vs $-16.2M). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs -32.6%).
Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.
Spire Global, Inc. is a space-to-cloud data and analytics company that specializes in the tracking of global data sets powered by a large constellation of nanosatellites, such as the tracking of maritime, aviation and weather patterns.
APYX vs SPIR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $15.8M |
| Net Profit | $-1.3M | $-28.0M |
| Gross Margin | 62.6% | 40.2% |
| Operating Margin | 0.1% | -164.1% |
| Net Margin | -6.8% | -176.6% |
| Revenue YoY | 34.7% | -26.9% |
| Net Profit YoY | 71.9% | 42.7% |
| EPS (diluted) | — | $-0.85 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.2M | $15.8M | ||
| Q3 25 | $12.9M | $12.7M | ||
| Q2 25 | $11.4M | $19.2M | ||
| Q1 25 | $9.4M | $23.9M | ||
| Q4 24 | $14.2M | $21.7M | ||
| Q3 24 | $11.5M | $28.6M | ||
| Q2 24 | $12.1M | $25.4M | ||
| Q1 24 | $10.2M | $34.8M |
| Q4 25 | $-1.3M | $-28.0M | ||
| Q3 25 | $-2.0M | $-19.7M | ||
| Q2 25 | $-3.8M | $119.6M | ||
| Q1 25 | $-4.2M | $-20.7M | ||
| Q4 24 | $-4.6M | $-48.8M | ||
| Q3 24 | $-4.7M | $-12.5M | ||
| Q2 24 | $-6.6M | $-16.6M | ||
| Q1 24 | $-7.6M | $-25.5M |
| Q4 25 | 62.6% | 40.2% | ||
| Q3 25 | 64.4% | 36.6% | ||
| Q2 25 | 62.3% | 48.9% | ||
| Q1 25 | 60.1% | 36.8% | ||
| Q4 24 | 63.0% | 32.4% | ||
| Q3 24 | 60.5% | 44.5% | ||
| Q2 24 | 61.7% | 43.0% | ||
| Q1 24 | 58.1% | 26.5% |
| Q4 25 | 0.1% | -164.1% | ||
| Q3 25 | -6.5% | -166.1% | ||
| Q2 25 | -22.6% | -122.7% | ||
| Q1 25 | -32.4% | -106.5% | ||
| Q4 24 | -21.4% | -144.1% | ||
| Q3 24 | -31.6% | -48.0% | ||
| Q2 24 | -45.7% | -48.6% | ||
| Q1 24 | -64.6% | -34.4% |
| Q4 25 | -6.8% | -176.6% | ||
| Q3 25 | -15.4% | -155.3% | ||
| Q2 25 | -33.2% | 623.4% | ||
| Q1 25 | -44.0% | -86.5% | ||
| Q4 24 | -32.5% | -225.2% | ||
| Q3 24 | -40.9% | -43.7% | ||
| Q2 24 | -54.0% | -65.2% | ||
| Q1 24 | -74.0% | -73.3% |
| Q4 25 | — | $-0.85 | ||
| Q3 25 | — | $-0.61 | ||
| Q2 25 | — | $3.72 | ||
| Q1 25 | — | $-0.77 | ||
| Q4 24 | — | $-1.93 | ||
| Q3 24 | — | $-0.50 | ||
| Q2 24 | $-0.19 | $-0.68 | ||
| Q1 24 | $-0.22 | $-1.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | $81.8M |
| Total DebtLower is stronger | $37.5M | — |
| Stockholders' EquityBook value | $14.5M | $112.9M |
| Total Assets | $66.8M | $211.0M |
| Debt / EquityLower = less leverage | 2.58× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.7M | $81.8M | ||
| Q3 25 | $25.1M | $96.8M | ||
| Q2 25 | $29.3M | $117.6M | ||
| Q1 25 | $31.0M | $35.9M | ||
| Q4 24 | $31.7M | $19.2M | ||
| Q3 24 | $28.0M | $36.6M | ||
| Q2 24 | $32.7M | $45.8M | ||
| Q1 24 | $37.3M | $63.7M |
| Q4 25 | $37.5M | — | ||
| Q3 25 | $37.5M | — | ||
| Q2 25 | $37.5M | — | ||
| Q1 25 | $37.5M | $103.7M | ||
| Q4 24 | $37.5M | $103.1M | ||
| Q3 24 | $37.5M | $4.9M | ||
| Q2 24 | — | $4.9M | ||
| Q1 24 | — | $123.1M |
| Q4 25 | $14.5M | $112.9M | ||
| Q3 25 | $5.8M | $133.1M | ||
| Q2 25 | $7.3M | $149.2M | ||
| Q1 25 | $10.5M | $3.7M | ||
| Q4 24 | $14.2M | $-11.7M | ||
| Q3 24 | $11.0M | $30.8M | ||
| Q2 24 | $14.7M | $40.3M | ||
| Q1 24 | $20.3M | $52.5M |
| Q4 25 | $66.8M | $211.0M | ||
| Q3 25 | $57.4M | $224.3M | ||
| Q2 25 | $58.2M | $239.5M | ||
| Q1 25 | $60.2M | $208.8M | ||
| Q4 24 | $64.8M | $193.6M | ||
| Q3 24 | $60.7M | $224.2M | ||
| Q2 24 | $65.4M | $230.8M | ||
| Q1 24 | $70.7M | $252.3M |
| Q4 25 | 2.58× | — | ||
| Q3 25 | 6.41× | — | ||
| Q2 25 | 5.17× | — | ||
| Q1 25 | 3.57× | 27.92× | ||
| Q4 24 | 2.64× | — | ||
| Q3 24 | 3.40× | 0.16× | ||
| Q2 24 | — | 0.12× | ||
| Q1 24 | — | 2.35× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $-4.3M |
| Free Cash FlowOCF − Capex | $-2.8M | $-16.2M |
| FCF MarginFCF / Revenue | -14.6% | -102.1% |
| Capex IntensityCapex / Revenue | 1.4% | 75.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-9.1M | $-92.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.5M | $-4.3M | ||
| Q3 25 | $-3.5M | $-12.0M | ||
| Q2 25 | $-1.2M | $-35.1M | ||
| Q1 25 | $-702.0K | $-8.4M | ||
| Q4 24 | $-2.9M | $-19.2M | ||
| Q3 24 | $-4.4M | $14.0M | ||
| Q2 24 | $-4.3M | $-4.4M | ||
| Q1 24 | $-6.3M | $-8.8M |
| Q4 25 | $-2.8M | $-16.2M | ||
| Q3 25 | $-4.1M | $-20.4M | ||
| Q2 25 | $-1.5M | $-38.7M | ||
| Q1 25 | $-757.0K | $-17.3M | ||
| Q4 24 | $-3.2M | $-24.3M | ||
| Q3 24 | $-4.6M | $5.1M | ||
| Q2 24 | $-4.6M | $-9.9M | ||
| Q1 24 | $-6.4M | $-15.9M |
| Q4 25 | -14.6% | -102.1% | ||
| Q3 25 | -31.5% | -161.3% | ||
| Q2 25 | -13.2% | -201.7% | ||
| Q1 25 | -8.0% | -72.6% | ||
| Q4 24 | -22.4% | -112.2% | ||
| Q3 24 | -40.0% | 17.8% | ||
| Q2 24 | -38.0% | -39.0% | ||
| Q1 24 | -62.2% | -45.7% |
| Q4 25 | 1.4% | 75.1% | ||
| Q3 25 | 4.0% | 66.2% | ||
| Q2 25 | 2.3% | 18.8% | ||
| Q1 25 | 0.6% | 37.3% | ||
| Q4 24 | 1.7% | 23.5% | ||
| Q3 24 | 1.3% | 31.2% | ||
| Q2 24 | 2.4% | 21.8% | ||
| Q1 24 | 0.3% | 20.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.29× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
